Adults with overweight or obesity who do not have type 2 diabetes may qualify for a clinical research study evaluating an investigational once-weekly medication for chronic weight management.
Adults with overweight or obesity who do not have type 2 diabetes may qualify for a clinical research study evaluating an investigational once-weekly medication for chronic weight management.
Overweight and obesity are chronic health conditions that can increase the risk of serious health problems, including high blood pressure, abnormal cholesterol, obstructive sleep apnea, cardiovascular disease, and fatty liver disease. Although healthy eating and regular physical activity are important for weight management, many adults continue to struggle with achieving and maintaining long-term weight loss.
Researchers are studying an investigational once-weekly injectable medication to learn whether it may help adults with overweight or obesity achieve meaningful weight loss when combined with lifestyle changes.
You may be able to join if you:
Meet all study eligibility requirements
Adults with overweight or obesity who do not have type 2 diabetes may qualify for a clinical research study evaluating
Adults 18 years of age and older with elevated inflammation levels and heart disease or certain health conditions that increase
Researchers are evaluating an investigational treatment for adults who have type 2 diabetes and cardiovascular disease and may be at
Researchers are evaluating an investigational oral treatment for adults who are overweight and may be at risk of developing certain
Researchers are evaluating an investigational medication that may help prevent the flu in people who are at higher risk of
Individuals with generalized anxiety disorder (GAD) who experience ongoing worry, stress, or difficulty managing anxiety symptoms may qualify for a